|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/577 | |
| G01N 33/53 | |||
| G01N 33/50 | |||
| G01N 33/68 |
| (11) | Number of the document | 2499494 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10829274.9 |
| Date of filing the European patent application | 2010-11-09 | |
| (97) | Date of publication of the European application | 2012-09-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/055997 |
| Date | 2010-11-09 |
| (87) | Number | WO 2011/057250 |
| Date | 2011-05-12 |
| (30) | Number | Date | Country code |
| 280897 P | 2009-11-09 | US |
| (72) |
MOVALIA, Mayur, US
ILLINGWORTH, Andrea, US
FAAS MCKNIGHT, Susan, US
ROTHER, Russell, P., US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
100 College Street, New Haven, CT 06510,
US
|
| (54) | REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS |
| REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS |